Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jane Dawson

Showing results (51-60 of 86) with videos related to

Pageof 9
Sort By:
Blood|April 25, 2024
Seven-year outcomes of venetoclax-ibrutinib therapy in mantle cell lymphoma: durable responses and treatment-free remissionsSasanka M Handunnetti, Mary Ann Anderson, Kate Burbury, et al.
Nature Communications|November 5, 2015
Multifocal clonal evolution characterized using circulating tumour DNA in a case of metastatic breast cancerMuhammed Murtaza, Sarah-Jane Dawson, Katherine Pogrebniak, et al.
Cancer Discovery|June 30, 2022
Alpelisib Monotherapy for PI3K-Altered, Pretreated Advanced Breast Cancer: A Phase II StudyPeter Savas, Louisa L Lo, Stephen J Luen, et al.
Nature|December 7, 2021
Multi-omic machine learning predictor of breast cancer therapy responseStephen-John Sammut, Mireia Crispin-Ortuzar, Suet-Feung Chin, et al.
Nature Cell Biology|January 12, 2023
Targeting Menin disrupts the KMT2A/B and polycomb balance to paradoxically activate bivalent genesChristina E Sparbier, Andrea Gillespie, Juliana Gomez, et al.
Molecular Cell|January 3, 2025
mRNA export factors store nascent transcripts within nuclear speckles as an adaptive response to transient global inhibition of transcriptionTobias D Williams, Ewa M Michalak, Kirstyn T Carey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 17, 2020
Circulating Tumor DNA Predicts Outcome from First-, but not Second-line Treatment and Identifies Melanoma Patients Who May Benefit from Combination ImmunotherapyGabriela Marsavela, Jenny Lee, Leslie Calapre, et al.
Nature Communications|March 18, 2017
Circulating tumour DNA reflects treatment response and clonal evolution in chronic lymphocytic leukaemiaPaul Yeh, Tane Hunter, Devbarna Sinha, et al.
Gut|February 3, 2026
Gut health is associated with clonal haematopoiesis in older adults with and without HIV: the ARCHIVE longitudinal cohort studyMark W Donoghoe, Hossain Ms Sazzad, Win Min Han, et al.
Nature|August 17, 2017
CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunityMarian L Burr, Christina E Sparbier, Yih-Chih Chan, et al.
Pageof 9

Showing results (51-60 of 86) with videos related to

Sort By:
Pageof 9
Blood|April 25, 2024
Seven-year outcomes of venetoclax-ibrutinib therapy in mantle cell lymphoma: durable responses and treatment-free remissionsSasanka M Handunnetti, Mary Ann Anderson, Kate Burbury, et al.
Nature Communications|November 5, 2015
Multifocal clonal evolution characterized using circulating tumour DNA in a case of metastatic breast cancerMuhammed Murtaza, Sarah-Jane Dawson, Katherine Pogrebniak, et al.
Cancer Discovery|June 30, 2022
Alpelisib Monotherapy for PI3K-Altered, Pretreated Advanced Breast Cancer: A Phase II StudyPeter Savas, Louisa L Lo, Stephen J Luen, et al.
Nature|December 7, 2021
Multi-omic machine learning predictor of breast cancer therapy responseStephen-John Sammut, Mireia Crispin-Ortuzar, Suet-Feung Chin, et al.
Nature Cell Biology|January 12, 2023
Targeting Menin disrupts the KMT2A/B and polycomb balance to paradoxically activate bivalent genesChristina E Sparbier, Andrea Gillespie, Juliana Gomez, et al.
Molecular Cell|January 3, 2025
mRNA export factors store nascent transcripts within nuclear speckles as an adaptive response to transient global inhibition of transcriptionTobias D Williams, Ewa M Michalak, Kirstyn T Carey, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 17, 2020
Circulating Tumor DNA Predicts Outcome from First-, but not Second-line Treatment and Identifies Melanoma Patients Who May Benefit from Combination ImmunotherapyGabriela Marsavela, Jenny Lee, Leslie Calapre, et al.
Nature Communications|March 18, 2017
Circulating tumour DNA reflects treatment response and clonal evolution in chronic lymphocytic leukaemiaPaul Yeh, Tane Hunter, Devbarna Sinha, et al.
Gut|February 3, 2026
Gut health is associated with clonal haematopoiesis in older adults with and without HIV: the ARCHIVE longitudinal cohort studyMark W Donoghoe, Hossain Ms Sazzad, Win Min Han, et al.
Nature|August 17, 2017
CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunityMarian L Burr, Christina E Sparbier, Yih-Chih Chan, et al.
Pageof 9